MétaCan
Menu
Back to cohort
Record W3110770353 · doi:10.1093/neuonc/noaa222.374

IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY

2020· article· en· W3110770353 on OpenAlexaff
Éric Bouffet, Sumedha Sudhaman, Jiil Chung, Jacalyn Kelly, Ailish Coblentz, Melissa Edwards, Tatiana Lipman, Cindy Zhang, Ayse B. Ercan, Lauren Sambira, Anne Bendel, Stefan Bielack, Elisabeth Koustenis, Deborah T. Blumenthal, Daniel C. Bowers, Alberto Broniscer, Annika Bronsema, Sara Carroll, Stefano Chiaravalli, Kristina A. Cole, Shlomi Constantini, Rebecca Loret De Mola, Gavin P. Dunn, Charlotta A. Frojd, David Gass, Karen Gauvain, Ben George, Nobuko Hijiya, Lindsey M. Hoffman, Jeffrey Knipstein, Ted Laetsch, Valérie Larouche, Álvaro Lassaletta, Scott Lindhorst, Alexander Lossos, Sandra Luna‐Fineman, Vanan Magimairajan, Gary Mason, Warren Mason, Maura Massimino, Oz Mordechai, Enrico Opocher, Michal Oren, Michael Osborn, Alyssa Reddy, Marc Remke, Sumita Roy, Magnus Sabel, David Samuel, Kami Wolfe Schneider, Santanu Sen, Duncan Stearns, David Sumerauer, Gregory A. Thomas, Patrick Tomboc, An Van Damme, Margaret E. Wierman, Ira Winer, Michal Zápotocký, David S. Ziegler, Stefanie Zimmermann, Rina Dvir, Gidi Rechavi, Carol Durno, Melyssa Aronson, Michael D. Taylor, Peter B. Dirks, Trevor J. Pugh, Adam Shlien, Cynthia Hawkins, Daniel A. Morgenstern, Uri Tabori

Bibliographic record

VenueNeuro-Oncology · 2020
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsMount Sinai HospitalCancerCare ManitobaPrincess Margaret Cancer CentreHospital for Sick Children
Fundersnot available
KeywordsMedicineImmune systemOncologyInternal medicineImmunotherapyBrain tumorImmune checkpointCancer researchImmunologyPathology

Abstract

fetched live from OpenAlex

Abstract Pediatric brain tumors with replication repair deficiency (RRD) are hypermutant and may respond to immune checkpoint inhibition (ICI). We performed a consortium registry study of ICI in recurrent RRD cancers. Clinical and companion biomarkers were collected longitudinally on all patients. Biomarkers included tumor mutational burden (TMB), neoantigens and genetic signatures obtained from whole genome and exome sequencing. Immune inference was obtained by RNAseq and T cell rearrangement was collected in the tumor and in blood throughout treatment. Of the 46 tumors on the study, 32 were brain tumors with glioblastoma in 96%. Rapid, objective responses (>50%) were observed in 50% of glioblastomas. Three year overall survival for the whole cohort was 48+/-8% which compares favorably with historical controls. Brain tumors fared worse with OS of 39+/-10% and late recurrences observed even after 2 years of therapy (p=0.02). Tumor size and acute “flare” constitute poor outcome throughout all cancers. While all tumors are hypermutant, TMB and predicted neoantigens correlated with response to ICI (p=0.02). Specific signatures extracted from SNVs and total mutations predicted response to ICI and favorable outcome (p=0.005). RNA inference and TCR reveal that the FLARE phenotype is mostly acute nonspecific immune response and not true progression. Finally, glioblastomas (n=8) which failed single agent ICI had favorable responses to combinational immunotherapies with prolonged survival of 65%+/-8% at one year after failure vs 0 for other patients (p=0.01). RRD glioblastomas exhibit favorable outcome and responses to ICI. Combinational therapies based on tumor and immune signatures of these cancers are necessary.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.350
Teacher spread0.294 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207